The Order further directs the parties to submit a proposed case management order for bellwether cases by December 1, 2017. The proposed order is to address, among other things, procedures for identifying bellwether cases, as well as protocols and procedures governing bellwether case-specific discovery. The parties are to identify bellwether cases pursuant to the proposed order no later than February 2, 2017. Bellwether case specific discovery may commence on February 8, 2017.
“Our firm is representing a number of plaintiffs in Stryker hip replacement lawsuits who allegedly experienced failure of an LFIT V40 femoral head. We will be paying close attention to the federal litigation’s bellwether process, as verdicts in these cases could provide insight into how other juries might decide similar claims,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to individuals who may have been harmed by Stryker’s LFIT Anatomic CoCr V40 Femoral Heads.
Stryker LFIT V40 Femoral Head Recall
Court documents indicate that at least 99 Stryker hip lawsuits involving LFIT V40 femoral heads are currently pending in the District of Massachusetts. Additional claims have been consolidated in a multicounty litigation now underway in New Jersey’s Bergen County Superior Court. (Stryker’s LFIT CoCr V40 Femoral Head, Case No. 624)
Many of the pending cases involve certain LFIT V40 femoral heads that were included in a Stryker hip recall announced in August 2016. According to Stryker’s “Urgent Medical Device Recall Notification,” the affected components had been associated with a higher-than-expected number of complaints involving taper lock failure.
Stryker hip replacement patients who experience taper lock failure are at risk for:
- Loss of mobility
- Adverse local tissue reaction
- Joint instability
- Bone fractures around the components
- Leg length discrepancy
- Need for revision surgery
Stryker’s notification was designated a Class II medical device recall by the U.S. Food & Drug Administration in November 2016. Class II designation indicates that a device may cause temporary or medically reversible adverse health consequences.
Compensation may be available to individuals who allegedly suffered pain, disability, and other complications resulting from the taper lock failure of a Stryker LFIT Anatomic CoCr V40 Femoral Head. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal’s “Plaintiffs’ Hot List,” recognizing the top plaintiffs firms in the country. This year’s nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
View original content with multimedia:http://www.prnewswire.com/news-releases/stryker-hip-replacement-lawsuits-move-forward-as-court-overseeing-federally-filed-lfit-v40-femoral-head-claims-issues-order-addressing-first-bellwether-trial-bernstein-liebhard-llp-reports-300546486.html
SOURCE Bernstein Liebhard LLP
Powered by WPeMatico